Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):544-5. doi: 10.1097/00126334-200204150-00017.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / physiology
  • Humans
  • Lymphocyte Activation
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • T-Lymphocyte Subsets / immunology
  • Viral Load

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors